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Autism prevalence in China is comparable
to Western prevalence
Xiang Sun1,2,3*, Carrie Allison2, Liping Wei4,5, Fiona E. Matthews6, Bonnie Auyeung2,7, Yu Yu Wu8, Sian Griffiths9,
Jie Zhang4, Simon Baron-Cohen2† and Carol Brayne1†
Abstract
Background: Autism prevalence in the West is approximately 1% of school age children. Autism prevalence in China
has been reported to be lower than in the West. This is likely due to at least two reasons: (1) most studies in China only
included the special school population, overlooking the mainstream school population; and (2) most studies in China
have not used contemporary screening and diagnostic methods. To address this, we tested total autism prevalence
(mainstream and special schools) in Jilin City, and mainstream school autism prevalence in Jiamusi and Shenzhen cities.
Methods: The study included a three-step process: (1) screening; (2) clinical assessment of ‘screen positives’ plus
controls; and (3) research diagnostic assessment of those meeting clinical threshold for concerns at step 2. Prevalence
estimates per 10,000 children aged 6–10 years old were weighted for study design using diagnostic criteria applied at
the research assessment stage.
Results: In Jilin City, 77 cases of autism were identified from a total population of 7258, equating to a prevalence of 108
per 10,000 (95% confidence interval (CI) 89, 130). In Shenzhen City: 21,420 children were screened and 35 cases of autism
were identified, resulting in a mainstream prevalence of 42 per 10,000 (95% CI 20–89). In Jiamusi City, 16,358 children
were screened, with 10 autism cases being identified, with a mainstream prevalence of 19 per 10,000 (95% CI 10–38).
Conclusions: Results from Jilin City, where both mainstream and special school data were available, revealed a
similar prevalence of autism in China to the West, at around 1%. Results from Shenzhen and Jiamusi cities,
where only mainstream data were available, prevalence is also in line with Western estimates. In all three
cities, new cases of autism were identified by the study in mainstream schools, reflecting current under-diagnosis.
Non-significant variation across different cities is seen indicating the need to explore potential variation of autism
across diverse Chinese regions with large sample sizes to achieve a fully robust national picture.
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Introduction
Autism spectrum conditions (henceforth autism) are char-
acterised by impairments in social interaction and com-
munication, alongside the presence of unusually repetitive
behaviour and narrow interests, difficulties adjusting to
unexpected change, and sensory hyper-sensitivity [1]. The
autism spectrum includes marked heterogeneity in
intelligence and language development. Population-based
epidemiological studies in the West have reported in-
creases in the prevalence of autism over time, ranging
from 30.8 per 10,000 in 2000 [2], to 157 per 10,000 in
2009 [3] to 169 per 10,000 in 2018 [4].
Autism was first described in Western cultures, and only
later recognised in Asian countries [5]. Understanding the
prevalence of autism in Asian countries is important be-
cause of its relevance to service planning, and for our un-
derstanding of the genetic and environmental contributing
factors of autism in diverse populations. In a South Korean
study in 2011, autism population prevalence was reported
to be 264 per 10,000 and 189 per 10,000 (95% CI 143–236)
in mainstream schools [6]. This high estimate may have
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resulted from the particular screening and assessment in-
struments used [7]. In China, most prevalence studies of
autism have only focused on one subtype, that is, children
with autism who have intellectual disability, omitting chil-
dren without intellectual disability, including those who
may previously have been diagnosed with Asperger syn-
drome (Appendix 1). This is despite the fact that 75% of
the autism spectrum does not have intellectual disability [4,
8]. A systematic review reported the prevalence of autism
in Mainland China, Hong Kong, and Taiwan to be 26.6 per
10,000 [8]. A recent review reported the pooled prevalence
of autism in China was 39.23 per 10,000 [9], which is sig-
nificantly lower than estimates from the West, suggesting
the possibility of under-diagnosis. The current study tests
two possible reasons for this lower autism prevalence in
China, namely, that in many studies (1) autism in main-
stream schools was overlooked; and (2) contemporary
screening and diagnostic methods were not used.
This study focuses on mainstream schools because the
Sui Ban Jiu Du policy encourages children with disabilities
to attend mainstream school [10], although in practice chil-
dren with moderate to severe autism are rarely enrolled in
mainstream schools [11]. We have previously reported an
autism prevalence estimate in mainstream primary schools
in Beijing of 119 per 10,000 (95% CI 53, 265) [14] which is
in line with Western autism prevalence estimates. We used
a validated screening tool, the Childhood Autism Spectrum
Test (CAST), and two research diagnostic assessment tools,
the Autism Diagnostic Observation Schedule (ADOS) [12],
and the Autism Diagnostic Interview-Revised (ADI-R) [13].
Most of the children identified in this study using these
contemporary screening and diagnostic measures had not
previously received an autism diagnosis, confirming under-
diagnosis of autism in mainstream schools.
Here, we report initial data from the China SCORE
(Social Communication Research and Epidemiology)
study, which aims to compare autism prevalence in
China with estimates from the West. First, we report
total autism prevalence (mainstream and special schools)
in Jilin City. Second, we report autism prevalence in
mainstream schools only in Shenzhen and Jiamusi cities.
We replicate just the mainstream prevalence in these
two cities, because mainstream prevalence has been so
neglected in previous studies in China (see Fig. 1).
Methods
Screening instrument
The CAST is a 37-item parent-completed questionnaire,
of which 31 items are scored. Thus, the total score
ranges from 0 to 31. It was originally validated in the
UK [15–19]. It has also been used in genetic studies
[20]. A Mandarin translation of the CAST has been used
to determine that using a cut-off of 15 (sensitivity = 84%,
specificity = 96%), the Mandarin CAST can be used as a
screening instrument in population-based epidemio-
logical research for autism in China [21].
Fig. 1 Location of three cities in China studied in phase I of the China SCORE study
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Population sample
We screened children attending mainstream primary
schools in the three cities. By definition, they are not the
children reported in previous prevalence studies of children
with autism in China attending special education schools.
The inclusion criteria for selecting each of the three cities
were as follows: the city should have (1) a median economic
level (neither extremely affluent nor extremely poor); (2)
an approximate sample size of 20,000 children aged 6 to
10 years old (children should not have had their 11th
birthday at the time of the study); (3) a professional capacity
to participate; (4) a median population mobility. These data
were obtained from the National Statistics Bureau (http://
www.stats.gov.cn/english/). Children in Mainland China are
only admitted to primary school after their sixth birthday.
In mainstream schools, grades 1 to 4 represent the age
group 6 to 10 years old. Three cities met these criteria.
In Jilin City, all mainstream schools (N = 14) and special
schools from special education (N = 3) in Fengman Dis-
trict for children aged 6–10 were invited, and all agreed to
participate in the study. The local residence records were
assessed and tracked for children with an autism diagnosis
who did not attend school in the target age range.
In Shenzhen City, there are six administrative districts.
Longgang District was selected for this study and out of
the 11 communities in this district, 7 agreed to participate.
There are 45 mainstream schools within these 7 commu-
nities, all of which agreed to participate. All caregivers of
children in grades 1 to 4 were invited to participate in
December 2013, representing a population of 20,553.
In Heilongjiang province, Jiamusi City was selected.
Twenty-seven mainstream primary schools in Jiamusi City
were invited, and all agreed to participate, representing a
population of 16,358 in grades 1 to 4 in Jiamusi City. No
special schools in Shenzhen and Jiamusi cities are included
in this report.
Case identification (diagnostic methods)
Most Western autism prevalence studies (e.g. US and UK)
conducted standardized diagnostic instruments (ADOS
and ADI-R) together with clinical diagnosis. In previous
Chinese prevalence studies, clinical diagnosis was adopted
as the gold standard. In order to be comparable with these
existing studies, both diagnostic approaches were adopted
in this study. This was in part to make sure that we cap-
tured all possible cases using a standardized protocol
across each city. The study was conducted in 3 steps:
Step 1: Screening
In all three cities in December 2013, the principals of
the participating schools were contacted and a screening
package was provided to the head teachers of classes in
grades 1 to 5 to distribute via students for their parents
to complete at home. Screening data collection and data
entry in Shenzhen City took 1 month to complete. In
Jiamusi, it took over 3 months to complete. One percent
of the data were double entered to quality control the
data entry. A report was provided for all CAST items
which were wrongly entered (enter value other than 0 or
1 or missing). If questionnaires missed more than five
scorable items, parents were contacted and asked to
complete the CAST a second time. A randomly selected
1% of questionnaires were checked for consistency in
data entry compared to the hard copy questionnaires.
Data entry was repeated if there was less than 95%
agreement between the hard copy and the electronic
data entry.
Step 2: Clinical assessment
Following quality checks on the data entry, all children in
the high-score group (CAST ≥15) were invited for a fur-
ther assessment. Five percent of children in the borderline
group (CAST 12–14) were randomly selected and invited
for a further assessment. If participation in the borderline
group was less than 50%, another random sample of 10%
of this borderline group was invited. In order to maximise
the identification of children with autism in the low-score
group (CAST ≤11), the school psychologists were asked to
select children for a further assessment if they had previ-
ous concerns about the child’s behaviour. The clinical as-
sessment team was blind to the screening status of all the
children during the assessment.
A maximum of 30 children from each school in the
low-score group were invited by the school psychologists.
This was due to the variability of uptake for the clinical as-
sessment in the low-score group and the variable resource
availability in different regions. Thus, each grade could have
invited a maximum of eight children. Participating families
were offered incentives (100 RMB) for taking part in the
clinical assessment. DSM-IV-TR and DSM-5 were the clin-
ical diagnostic criteria used in this study by the child psy-
chiatrists. The clinical assessment team comprised child
psychiatrists with expertise in autism, who were approved
by the China Disabled Persons’ Federation (CDPF).
Agreement between clinicians of diagnostic outcome
was established in three stages. First, CDPF in each city
recommended child psychiatrists with expertise in diag-
nosing children with autism. Second, a core clinical expert
team developed a diagnostic agreement test for child psy-
chiatrists. We invited six child psychiatrists considered to
be the most experienced in the diagnosis of autism in
Mainland China to develop a test of diagnostic agreement.
Ten children aged six to 10 years old in Shenzhen in April
2014 were selected, comprising N = 8 children with aut-
ism, N = 1 child with other developmental difficulties not
related to autism and N = 1 neurotypical child. They were
initially assessed by the first author and their diagnoses
confirmed using the ADOS and ADI-R.
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Second, they were randomly assigned to, and assessed
independently by, the six child psychiatrists. When one
child psychiatrist conducted a clinical interview, another
psychiatrist observed. The diagnoses of the 10 children
were discussed and agreed between the first author and
the six child psychiatrists. This process was video recorded
and edited to produce a training DVD for other child psy-
chiatrists to use to establish diagnostic agreement.
Finally, the clinical experts completed the diagnostic
agreement test and joined the clinical assessment team if
s/he achieved diagnostic agreement of 80% or above.
This standardised clinical diagnostic protocol was estab-
lished in order to ensure reliability of the clinical diagnosis
across each region. The clinical assessments consisted of
three parts: a face-to-face interview with parents; direct ob-
servation and communication with the child using toys;
and questions relating to the child’s general development,
together with completing the diagnostic forms. Two stan-
dardised diagnostic forms were provided to each child
psychiatrist. One was the DSM-IV-TR criteria and the other
was DSM-5 criteria. A third document was a supplemen-
tary question list based on examples from DSM-5 and
DSM-IV-TR items. These questions were drawn from the
ADI-R. This document was provided as a guide for possible
questions to enquire about, but was not compulsory for the
psychiatrists to use. The final clinical diagnosis was made in
three categories: autism, suspected autism, and not-autism.
The psychiatrist was asked to provide notes on the diagnos-
tic form if they believed the child to have a developmental
condition that was not related to autism.
Step 3: Research diagnostic assessments
After the clinical assessment (step 2), children whose clin-
ical diagnostic outcome was autism or suspected of autism
were invited for a research diagnostic assessment using
the ADOS, the ADI-R. A measure of IQ was obtained
using the Raven Progress Matrix (RPM) [16]. The Chinese
version of the RPM was used, which is a validated measure
and applicable to individuals from the age of 5 to 75 in
Mainland China [23]. Ten children in Shenzhen City
whose clinical diagnostic outcome was not autism were
also randomly selected for a research diagnostic assess-
ment to confirm whether there were potential cases of
autism being missed by the clinical diagnostic team.
ADOS and the ADI-R were conducted by researchers who
had obtained research reliability prior to the study. Autism
cases were defined using a consensus case definition.
If the child scored above the cut-offs for autism or
autism spectrum on both the ADOS and the ADI-R, a
research diagnosis of autism was made. If the child
scored on both the ADOS and the ADI-R, or if the child
scored above the diagnostic algorithm threshold on either
the ADOS or the ADI-R, he or she was referred to a third
clinical child psychiatrist in the clinical team. The third
child psychiatrist used all information available from the
assessment together with clinical judgement and consult-
ation with DSM-IV-TR/DSM-5 diagnostic criteria. If there
was any disagreement between the clinical diagnosis and
research diagnosis (using the ADOS and ADI-R), a final
diagnosis was made by consensus by the two child psychi-
atrists (using DSM-IV-TR and DSM-5) and the research
assessment examiner (using the ADOS and ADI-R). In
Jilin City, children with autism who were tracked from the
local residence records were reassessed by child psychia-
trists using the ADOS and ADI-R. The final diagnosis of
these children was made by consensus diagnosis. More
detailed methods are presented in Additional file 1.
Data analysis
The distribution of CAST scores was examined using the
skewness-kurtosis test. The impact of non-participation in
the assessment phase was examined by comparing the
characteristics of participants who took part in the assess-
ment with those who were invited but refused to partici-
pate. The randomly selected sample based on the random
number table (5%) from the borderline group (12–14) and
the low-score group (≤ 11) who participated in the further
assessment were compared with those who were not in-
vited and who refused to participate separately. Differ-
ences between children who participated in the clinical
diagnosis were examined in two steps.
For high and low CAST score groups, differences be-
tween children who did and did not complete the clinical
assessments were examined. For the borderline CAST score
group, children were divided into three groups: (1) children
who were invited and completed the clinical assessments;
(2) children who were invited but did not complete the as-
sessments; (3) children who were not invited for a clinical
assessment. The skewness-kurtosis test was used to exam-
ine the normality of the score distribution.
For ordered categorical or continuous and non-normally
distributed variables, the Mann-Whitney test was used to
compare medians for two groups, while the Kruskal-Wallis
H test was used for multiple groups. Unpaired t tests and
one-way analyses of variance (ANOVA) were adopted to
compare means for normally distributed continuous vari-
ables, and the chi-square tests were used to examine differ-
ences in proportions for nominal or unordered categorical
variables. Whenever the numbers were small, a Fishers’
exact test was used. All the analyses were conducted using
STATA 14.0.
For all missing values on the CAST, a score of 0 was
given to generate a minimum score. A score of 1 was
given to generate a maximum score. A middle score was
generated using the equation: (minimum +maximum)/2.
Inverse probability weighting using sampling weights
was applied to adjust the prevalence estimates for the
known non-response to the invitation for assessment
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within each sampling score group [2, 3]. This strategy
was used because of the two-phase sampling strategy.
The inverse probability was the empirical weight gener-
ated according to the response to the screen and to the
participation rate in the further assessment phase. A raw
prevalence estimate was generated by first using the in-
verse probability weighting. Non-response weights were
calculated between those invited for a clinical assess-
ment and those that did not take part, allowing for dif-
ferences in response for age, sex, education of the
parents, and screening score (including missing item in-
formation). Any further non-response from the clinical
assessment to the research assessment was also adjusted
for using inverse probability weighting methods. Missing
data were imputed, and an adjusted prevalence was pro-
vided after adjusting for age, sex, and the non-response
differences. 95% confidence intervals were calculated ac-
cordingly by applying the weighted count.
Results
Jilin City: prevalence estimate
The characteristics of the parents are shown in Table 1. The
study population in mainstream schools was 7167 (Fig. 2).
Of these, 3282 (45.8%) were boys, 2883 (40.2%) were girls,
for the rest 1002 (14.0%), and gender information was miss-
ing. The mean age of the sample was 8.5 years old (SD=
1.1). Occupational and educational level of the parents was
also collected and divided into five categories [4].
The median score on the CAST was 8 (IQR 5, 11; range 0,
23). Of the 6149 screened children from mainstream schools
whose data were available for analysis (step 1), 477 (7.8%)
were in the high-score group on the CAST (≥ 15), 745
(12.1%) were in the borderline group (12–14), and 4927
(80.1%) were in the low-score group (≤ 11). All 477 children
in the high-score group completed the clinical assessment
(step 2) (participation rate = 100%). In the borderline group,
33 children participated of the 37 invited (89%). Nine chil-
dren of the 10 invited in the low-score group participated
(90%). Seven children were judged at clinical assessment to
have autism and two were judged to have suspected autism,
all of whom were from the high-score group. These nine
children were invited for a research diagnostic assessment
(step 3), and they all received a research diagnosis of autism.
Thus, when adjusting for non-response, the prevalence
of autism in mainstream primary schools was 14.6 per
10,000 in Jilin City. Mean IQ score for the nine children
was 105. Using the same three-step design and methods,
68 additional children with autism were found from 91
children studied from other settings serving this geo-
graphical locality. These included 19 from special schools,
43 from private intervention centres, and 6 children from
the community not attending school. These six children
did not have the resources to attend any schools or inter-
vention centres. Thus, the overall prevalence estimate for
autism in Jilin City (total population prevalence) was
108.0 per 10,000 (or 1 in 92) (95% CI 87.0, 135.0).
Shenzhen City: prevalence estimate
21,420 out of 21,553 (participation rate = 99.4%) screening
questionnaires were completed and returned to the study
team from 45 schools (Fig. 3). Of these, 11,878 (55.5%)
were boys and 9312 (43.5%) were girls. None of these chil-
dren had a diagnosis of autism before this study. For 230
(1.1%), gender was missing. Fifty-five children were
excluded because they were younger than 6 years old and
86 were excluded because they were over 11 years old. Six
were excluded because their year of birth was illegible. Of
the 20,802 children (step 1) aged 6 to 10 (97.1%), 1187
(5.7%) were in the high-score group on the CAST (scoring
≥ 15), 2542 (12.2%) were in the borderline group (scoring
12–14), and 17,073 (82.1%) were in the low-score group.
In the high-score group, N = 1187 were invited for
assessments, of whom 797 took part in the clinical
assessment (step 2), with 114 referred for a research diag-
nostic assessment (step 3). One hundred four of these
completed the research diagnostic assessment (91.2%),
resulting in 34 children being diagnosed with autism.
In the borderline group, a random sample of 5% (123 stu-
dents) were invited for a clinical assessment (step 2) and 70
completed (56.9%), with three referred for a research diag-
nostic assessment (step 3), all of whom completed. One
child was diagnosed with autism at the research assessment.
In the low-score group, 23 children were identified by
teachers with concerns about their behaviour and under-
took the clinical assessment (step 2), of whom 6 were
referred for and undertook the research diagnostic as-
sessment (step 3). However, none of these six children
met autism diagnostic criteria.
The 35 cases confirmed by the research diagnostic
assessment equate to a prevalence of 42.3 per 10,000 chil-
dren age 6 to 10 in mainstream education (95% CI 20.1–
88.6) after adjusting for non-response (or 1 in 238). The
prevalence estimate for boys was 38.8 (95% CI 26.5–56.7)
and girls 44.9 (95% CI 10.1–196) per 10,000. Mean IQ score
was 114 in these 35 children with autism. More detailed re-
sults of clinical and research diagnosis are in Tables 2 and 3.
Jiamusi City: prevalence estimate
16,358 questionnaires were distributed to 27 schools
with children aged 6 to 10 years old (Fig. 4). None of
these children had a diagnosis of autism before this
study. All were returned and available for analysis (par-
ticipation rate = 100%). Of these, 8326 (50.9%) were boys
and 7853 (48.0%) were girls. For 179 (1.1%), gender was
missing. Age was within the correct range for 15,663 chil-
dren (95.8%). The remaining children were excluded be-
cause they were younger than 6 years old (n = 195) or older
than 11 years (n = 695), or their year of birth was illegible
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Table 1 Characteristics of parents in three cities
Characteristics Category Shenzhen City Jiamusi City Jilin City
Number (%) Number (%) Category Number (%)
Mother’s education Junior high school 6980 33.6 6413 41.5 Junior high school 1522 23.7
High school 8316 40.0 5211 33.7 High school 2009 31.3
College 4872 23.4 3373 21.8 College 2061 32.1
Graduate school 154 0.7 252 1.6 Graduate 276 4.3
Missing 479 2.3 219 1.4 Missing 552 8.6
Father’s education Junior high school 4951 23.8 6092 39.4 Junior high school 1104 17.2
High school 8208 39.5 5337 34.5 High school 1900 29.6
College 6604 31.8 3445 22.3 College 2408 37.5
Graduate school 374 1.8 310 2.0 Master or higher 372 5.8
Missing 665 3.2 284 1.8 Missing 636 9.9
Mother’s occupation Government officer 89 0.4 438 2.8 Worker or farmer 1682 26.2
Company clerk 6173 29.7 1858 12.0 Clerk 1438 22.4
Technical staff 1393 21.7
Industry 1475 7.1 1806 11.7 Manager 161 2.5
Self-employed 5461 26.3 4655 30.1 Own-business 995 15.5
Worker 1578 7.6 1354 8.6 Missing 751 11.7
Student 32 0.2 7 0.1
Farmer 937 4.5 2032 13.1
Unemployed 4002 24.1 3109 20.1
Missing 55 0.3 209 1.4
Father’s occupation Government officer 293 1.4 782 5.1 Worker or farmer 1367 21.3
Company clerk 7518 36.1 1628 10.5 Clerk 1830 28.5
Industry 1836 8.8 1634 10.6 Technical staff 1284 20.0
Self-employed 7617 36.6 5022 32.5 Manager 276 4.3
Worker 1690 8.1 2771 17.9 Own-business 1021 15.9
Missing 642 10.0
Student 10 0.1 5 0.0
Farmer 588 2.8 2071 13.4
Unemployed 1199 5.8 1305 8.4
Missing 51 0.3 250 1.6
Mother’s age ≤ 24 61 0.3 36 0.2
25–30 2552 12.3 1981 12.8
31–34 11,921 57.3 8603 55.6
35–40 4816 23.2 945 6.1
≥ 40 410 2.0 2 0.0
Missing 1042 5.0 3901 25.2
Father’s age ≤ 24 32 0.2 25 0.2
25–30 677 3.3 769 5.0
31–34 10,468 50.3 10,229 66.1
35–40 7577 36.4 1589 10.3
≥ 40 985 4.7 2 0.0
Missing 1063 5.1 3854 18.5
Income ≤ 1999 829 4.0 2699 17.5
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(n = 617). Of the 15,663 children within the age range (6–
10), 901 (5.8%) fell in the high-score group (≥ 15), 1822
(11.6%) were in the borderline group (12–14) and 12,940
(82.6%) were in the low-score group (Appendix 1).
In the high-score group, 414 (45.9%) of the invited 901
took part in the clinical assessment (step 2), with 20 referred
for and completing a research diagnostic assessment (100%)
(step 3), among whom 9 received a diagnosis of autism.
In the borderline group, a random sample of 5% (n = 87)
and a second sample of 10% (n = 181) were invited for a
clinical assessment (step 2). One hundred forty-four of
these completed this assessment (8% response (7/87) from
the first 5% random sample, and 76% (139/181) from the
second), within which one child was referred for a
research diagnostic assessment (step 3), but this child did
not meet research diagnostic criteria.
In the low-score group, 750 children were identified
by teachers and school psychologists as showing con-
cerns, and all received a clinical assessment (step 2), of
whom three were referred for and completed a research
diagnostic assessment (step 3), with one child meeting
autism diagnostic criteria.
The 10 cases equate to a prevalence of 19.0 per 10,000
children age 6–10 (95% CI 9.7–37.5), adjusted for
non-response. The prevalence for boys was 35.9 (95%CI
17.4–73.8) and girls 3.2 (95%CI 0.4–22.6) per 10,000.
Mean IQ for the 10 children was 116. The large differ-
ences seen between Jiamusi and Shenzhen cities did not
Table 1 Characteristics of parents in three cities (Continued)
Characteristics Category Shenzhen City Jiamusi City Jilin City
Number (%) Number (%) Category Number (%)
2000–3999 3355 16.1 5252 34.0
4000–5999 3836 18.4 3880 25.1
6000–7999 3050 14.7 1704 11.0
8000–9999 2389 11.5 569 3.7
≥ 10,000 5399 26.0 569 3.7
Missing 1944 9.4 795 5.1
Fig. 2 Flowchart of Jilin City
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reach statistical significance either as a crude effect
(OR = 0.45 95% CI 0.16–1.23, p = 0.12) or after adjusting
for age, sex, income, and education differences between
the two regions (OR = 0.39, 95% CI 0.12–1.30, p = 0.13).
The results of the three cities are shown in Fig. 5 (with
data from the mainstream schools and from the whole
population), together with data from the recent CDC
survey from the USA for comparison.
Non-responders
In Shenzhen, non-response to the invitation for a clinical
diagnosis was related to mother’s education (the higher
the education the less likely the child was to take part,
OR = 0.8, p = 0.016). Invited individuals in the borderline
group were less likely to respond than those in the high
group (OR = 0.6, p = 0.02). The following variables were
not significantly related to non-response: father’s educa-
tion, mother’s or father’s age or occupation, who com-
pleted the questionnaire (mother or father), income,
being born in the city, age or sex of child (after adjusting
for mother’s education), or CAST score (within groups).
However, in Jiamusi, the patterns were slightly different:
children were more likely to take part if they were older,
and with response differences for both mother’s educa-
tion and father’s education, and again with those less
educated more likely to take part. Income was also inversely
related to participation, with those on lowest incomes most
likely to participate.
The following variables were not significantly related
to response rate: mother’s or father’s age, who completed
Fig. 3 Mainstream-school screening in Shenzhen City
Table 2 Clinical and research diagnosis across different CAST score groups in Shenzhen
Shenzhen City Clinical diagnosis Research diagnosis
Non-autism
(%)
Autism or
suspected
autism (%)
ADHD Developmental delay
(%)
Not assessed
(%)
Total
(%)
Non-autism
(%)
Autism
(%)
Missing
(%)
Total
(%)
High score 670 (56.4) 114 (9.6) 12 (1.0) 1 (0.1) 390 (32.8) 1187 (100.0) 60 (57.7) 34 (32.7) 10 (9.6) 104 (100.0)
Borderline 67 (2.6) 3 (0.1) 0 (0.0) 0 (0.0) 2472 (97.3) 2542 (100.0) 2 (2.6) 1 (0.1) 0 (97.3) 3 (100.0)
Low 17 (0.1) 6 (0.0) 0 (0.0) 0 (0.0) 17050 (99.9) 17073 (100.0) 6 (0.1) 0 (0.04) 0 (99.9) 6 (100.0)
Total 754 (3.6) 123 (0.6) 12 (0.1) 1 (0.0) 19912 (95.7) 20802 (100.0) 87 (3.6) 35 (0.6) 0 (95.7) 113 (100.0)
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the questionnaire, or mother’s occupation. After adjust-
ing for the other factors, father’s education and father’s
occupation (higher social status occupations were less
likely to take part), and child’s age were the strongest
factors related to non-response. In addition, the higher
the CAST score the less likely the child was to take part,
though this effect was small. More detailed results are
presented in Appendix 2 Detailed results’ tables.
Discussion
Key findings
There are four key findings from this study. First, results
from Jilin City where both mainstream and special
school data were available revealed a similar prevalence
of autism in China to the West, at around 1% [24–27].
Second, in Shenzhen and Jiamusi cities, where only
mainstream data were available, prevalence is also in line
with Western estimates [9, 26]. Third, in all three cities,
new cases of autism were identified by the study in
mainstream schools, reflecting current under-diagnosis.
Finally, non-significant variation across different cities is
seen indicating the need to explore potential variation of
autism across diverse Chinese regions with large sample
sizes to achieve a fully robust national picture.
The prevalence estimate in mainstream schools in Jilin
was 14.6 per 10,000. In Shenzhen, it was 42.3 per 10,000
and 19.0 per 10,000 in Jiamusi. In Jilin, where prevalence
included those children with autism identified from spe-
cial education and other settings outside mainstream
population, the prevalence estimate was 108 per 10,000.
Fig. 4 Flowchart of Jiamusi City
Table 3 Clinical and research diagnosis across different CAST score groups in Jiamusi
Jiamusi City Clinical diagnosis Research diagnosis
Non-ASC
(%)
ASC or
suspected
ASC (%)
ADHD DD (%) ID Not assessed
(%)
Total
(%)
Non-autism
(%)
Autism
(%)
Missing
(%)
Total
(%)
High score 390 (43.3) 20 (2.2) 0 (1.0) 1 (0.1) 3 (0.3) 487 (54.1) 901 (100.0) 11 (55.0) 9 (45.0) 0 (0.0) 20 (100.0)
Borderline 143 (7.9) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 1678 (92.1) 1822 (100.0) 1 (100.0) 0 (0.0) 0 (0.0) 1 (100.0)
Low 747 (5.8) 3 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 12190 (94.2) 12940 (100.0) 2 (66.7) 1 (33.3) 0 (0.0) 3 (100.0)
Total 1280 (8.2) 24 (0.2) 0 (0.0) 1 (0.0) 3 (0.0) 14355 (91.7) 15663 (100.0) 14 (58.3) 10 (41.7) 0 (0.0) 24 (100.0)
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Strengths
The strengths of this first large-scale study of autism in
China are several. We used a total population approach
covering all services in one city and mainstream schools
in the other two. The response rate was high, much higher
than has ever been achieved in the West. We used inter-
nationally agreed standardised screening and diagnostic
instruments in all three cities. This included a Mandarin
Chinese version of the CAST that has previously been
shown to have acceptable validity in a Chinese population
[21]. The Western-developed diagnostic instruments
ADI-R and ADOS were used in combination with clinical
diagnosis by Chinese child psychiatrists and were con-
firmed to be acceptable within a Chinese clinical setting,
finding that these produce similar prevalence estimates
across both Western and Asian cultures.
After screening (step 1), this study used local child psy-
chiatrists as an additional selection step (step 2) prior to be-
ing followed up with research diagnostic assessments (step
3) which is a modification from previous prospective epi-
demiological studies in other countries, reducing the vol-
ume of false positives which otherwise may be experienced
in such studies [3, 4, 6, 26]. The population size covered by
the sampling in each of the three cities was large and in-
cluded both screen-positives, screen-borderline, and
screen-negatives in all three score groups for diagnostic as-
sessments. Finally, our analytical methods took this staged
study design into account, along with drop out between the
stages, in our estimation of confidence intervals.
Limitations
Despite these strengths, there are several limitations. First,
according to the recruitment criteria, the sample for the
cities was representative for the local region but is not yet
nationally representative of China; hence, the hope for the
China SCORE project is to map autism prevalence in 10
cities in total. It is important for national policy to report
data from these first three cities, and our on-going data
collection in the seven other cities will serve to further in-
form national policy and future research directions. The
impact of differences in the three regions is difficult to es-
tablish given considerable variation in economic status
and demographic characteristics for the three regions.
In Shenzhen and Jiamusi cities, not all of the schools
took part in this study. Non-participation is not unusual
in any epidemiological studies, particularly those address-
ing neuropsychiatric disorders. The influence of non-par-
ticipation in epidemiological studies of autism has been
discussed [28, 29], especially those with low participation
rates. As participation has to be voluntary under ethical
codes, the participation of each local government relies on
an existing collaboration. It is not uncommon that some
communities will not wish to take part. In addition, indi-
vidual and family participation is subject to the usual
human research ethical codes and participation is volun-
tary. The participation rate of the communities in this
study is much higher than most of the prevalence studies
of autism internationally. Although there will be non-par-
ticipation effects, these will be much less marked than
those experienced by other such studies.
The use of both DSM-IV-TR and DSM-5 may lead to
concerns about the differences in prevalence across regions
as differences between the DSM-IV-TR and the DSM-5
exist. The DSM-5 has not been fully adopted in most clinical
settings in China; therefore, the DSM-IV-TR criteria were
also used in this study. The reasons for this were two-fold.
First, to ensure there was consistency among child psychia-
trists across the regions, and second, to ensure comparabil-
ity between existing diagnosed children and newly
diagnosed children. The Chinese DSM-5 was also provided
Fig. 5 Prevalence of autism in China vs. USA
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to each psychiatrist to assist the diagnostic process. Children
who were suspected to have autism according to either
DSM-IV-TR or DSM-5 criteria were invited for a research
assessment using the ADOS and the ADI-R. Thus, the po-
tential impact due to differences between the DSM-IV-TR
and the DSM-5 in this study should be minimised.
Missed diagnoses by child psychiatrists during clinical as-
sessments serve to lower prevalence estimates. In the
current study, we reduced the likelihood of this happening
by developing a diagnostic agreement test that could be
used by all psychiatrists in all participating regions. Psychia-
trists recommended by CDPF only joined the final clinical
assessment team if s/he achieved a diagnostic agreement of
80% or above. Thus, the final prevalence estimate should
not be compromised by changes in personnel between the
clinical diagnosis and the research diagnosis.
There could be variations in the inclusion of children with
autism in mainstream schools that may have influenced
prevalence estimates across the three cities. To date, there
has been no unified healthcare system and health insurance
policy in Mainland China for autism [9]. The current educa-
tion inclusion policy only recommends mainstream schools
to include children with disabilities, but this is not
mandatory [9, 30]. In three cities, the participation rates of
local schools during the screening and diagnostic phases
were different. This could be explained by a number of is-
sues. First, recognition and awareness of autism within the
mainstream population in the three cities may be different.
Data from the non-responders suggested that in Shenzhen,
which is a more advanced city where awareness and under-
standing about autism might be higher, the mothers edu-
cated to a higher level were more likely to participate. In
contrast, in Jiamusi city where the economic status was rela-
tively lower, awareness about autism might be lower, and
therefore parents educated to a higher level and those with
higher socioeconomic status were less likely to participate.
Second, involvement and support from the local govern-
ment for this study was different in each city. Third, partici-
pation in the study is voluntary, so the willingness of the
parents to participate may be different. The attitude of the
parents towards incentives could be different. There have
been studies focusing on the potential selection bias in
prevalence studies of autism [28, 29]. Parental denial about
autism may also contribute to differences in participation
rates. It is possible that when parents realised that their child
might have more difficulties than other children, they were
less likely to participate. Thus, in both Shenzhen and Jiamusi
cities, children who scored in the high score group were less
likely to participate than those in the borderline score group.
These factors might lead to a higher prevalence of autism in
more advanced cities such as Shenzhen city and a lower
prevalence in less developed cities such as Jiamusi city.
Another limitation of this study was that there was
no information available concerning the prevalence of
autism in special education in Shenzhen and Jiamusi cit-
ies. The goal of the study was to report the prevalence
of autism in a previously neglected population, i.e., the
mainstream school population. In China, most of the
previously identified cases of autism are children with
severe autism, including those with intellectual disability.
To date, nearly all of the prevalence studies of autism in
China have been carried out in special education settings
but not in mainstream settings [8, 9]. In contrast to de-
veloped countries, most children with moderate to se-
vere autism in China do not attend mainstream schools.
They would not be admitted during the application
process for kindergartens and primary schools [9, 30].
Children with autism who do not have intellectual dis-
ability are more likely be identified and given a diagnosis
of autism in developed countries than in China [30, 31].
This is one of the reasons why previous prevalence esti-
mates were much lower than those from the developed
countries. In 2015, we reported our pilot study in two
mainstream schools in Beijing which showed there were
children with autism in mainstream schools. The preva-
lence in those two schools was 119 per 10,000 [14]. The
current study was carried out in a large mainstream
population in those three cities.
Conclusions
The prevalence estimate indicates that the prevalence of
autism in China is similar to estimates in Western coun-
tries. As China has such a large population, addressing
this under-diagnosis of children with autism in main-
stream schools would need major improvement in health-
care and education systems to support their families.
Children with autism in primary schools are mostly chil-
dren with average IQ (mean IQ > 100, Additional file 1).
These children urgently need support to understand the
difficulties and challenges they might face in the future to
prepare themselves for school and the workplace.
During previous and current studies, we found there
was a lack of awareness and knowledge among school
professionals about autism [5, 10, 11]. Many schools do
not have special education teachers. Many parents had
never heard of autism prior to the study. If sufficient
information is provided to parents at the hospital paedi-
atric department, this could profoundly improve early
detection of autism. Recognition of the role that child
psychiatrists play throughout the life-course needs to be
improved in China. Even among school psychologists,
many of them had no awareness about symptoms of
autism before we gave them training about screening
and diagnosis. Special teachers and school psychologists
need to be trained with skills and intervention strategies
to help children who may be struggling because of social
and communication difficulties that may be related to
autism.
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Appendix 2
Table 6 Age and sex distribution of Shenzhen City sample
Age Sex Missing Total (%)
Boys Girls
6 2179 1879 7 4065 (19.0)
7 3237 2459 16 5712 (26.7)
8 3110 2387 20 5517 (25.8)
9 2454 1968 12 4434 (20.7)
10 632 420 2 1054 (4.9)
Others 266 199 173 638 (3.0)
Total 11,878 9312 230 21,420 (100)
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Table 7 Characteristics of Shenzhen sample within age range during clinical assessments
Variables n (%) Group 1: CAST ≥ 15 Group 2: 12–14 Group 3: ≤ 11
Completed Not
completed
Invited and
completed
Invited but not
participated
Not
invited
Invited Not
invited
Number 796 (67) 391 (33) 70 (3) 53 (2) 2419 (95) 23 (0.1) 17,050 (99.9)
CAST score Median (IQR) 16 (15,17) 16 (15.17) 13 (12, 14) 13 (12, 14) 13 (12, 13) 13 (12, 14) 13 (12, 13)
Mean (SD) 15.5 (3.7) 15.8 (3.0) 12.2 (2.5) 12.6 (1.7) 12.6 (1.6) 12.2 (2.5) 12.6 (1.6)
Age Mean (SD) 8.2 (1.1) 8.3 (1.1) 7.9 (1.1) 8.4 (1.0) 8.2 (1.1) 7.9 (1.1) 8.2 (1.1)
Sex
Boys 527 (66) 265 (68) 40 (57) 35 (66) 1548 (64) 22 (96) 9185 (54)
Girls 241 (30) 126 (32) 30 (43) 18 (34) 866 (36) 1 (4) 7840 (46)
Missing 28 (3.5) 0 (0) 0 (0) 0 (0) 5 (0.2) 0 (0) 25 (0.2)
Mother’s age
≤ 24 5 (0.6) 1 (0.3) 0 (0) 0 (0) 11 (0.5) 0 (0.0) 44 (0.3)
25–30 88 (11.1) 47 (12.0) 8 (11.4) 5 (9.4) 337 (13.9) 4 (17.4) 2063 (12.1)
31–34 419 (52.6) 211 (54.0) 35 (50.0) 31 (58.5) 1330 (55.0) 12 (52.2) 9883 (58.0)
35–40 184 (23.1) 110 (28.1) 14 (20.0) 12 (22.6) 565 (23.4) 7 (30.4) 3924 (23.0)
≥ 41 19 (2.4) 2 (0.5) 3 (4.3) 1 (1.9) 40 (4.3) 0 (0.0) 345 (2.0)
Missing 81 (10.2) 20 (5.1) 10 (14.3) 4 (7.6) 136 (5.6) 0 (0.0) 791 (4.6)
Father’s age
≤ 24 2 (0.3) 1 (0.3) 0 (0.0) 0 (0.0) 6 (0.3) 0 (0.0) 23 (0.1)
25–30 21 (2.6) 8 (2.1) 1 (1.4) 2 (3.8) 92 (3.8) 2 (8.7) 551 (3.2)
31–34 393 (49.4) 183 (46.8) 34 (48.6) 30 (56.6) 1215 (50.2) 9 (39.1) 8604 (50.5)
35–40 265 (33.3) 169 (43.2) 21 (30.0) 18 (34.0) 869 (37.0) 11 (47.8) 6197 (36.4)
≥ 41 45 (5.7) 12 (3.1) 5 (7.1) 2 (3.8) 85 (3.5) 1 (4.4) 835 (4.9)
Missing 70 (8.8) 18 (4.6) 9 (12.9) 1 (1.9) 125 (5.2) 0 (0.0) 840 (4.9)
Mother’s education
Junior high or lower 366 (46.0) 168 (43.0) 35 (50.0) 18 (34.0) 1023 (42.29) 11 (47.8) 5359 (31.4)
High school 252 (31.7) 130 (33.3) 25 (35.7) 21 (39.6) 908 (37.5) 8 (34.8) 6972 (40.9)
College or university 116 (14.6) 71 (18.2) 5 (7.1) 12 (22.6) 416 (17.2) 4 (17.4) 4248 (24.9)
Graduate school 8 (1.0) 6 (1.5) 0 (0.0) 1 (1.9) 14 (0.6) 0 (0.0) 125 (0.7)
Missing 54 (6.8) 16 (4.1) 5 (7.1) 1 (1.9) 58 (2.4) 0 (0.0) 346 (2.0)
Father’s education
Junior high or lower 264 (33.1) 115 (29.4) 22 (31.4) 16 (30.2) 729 (30.1) 10 (43.5) 3795 (22.3)
High school 285 (35.8) 144 (36.83) 30 (42.9) 1040 (40.9) 988 (40.8) 7 (30.4) 6732 (39.5)
College or university 175 (22.0) 101 (25.8) 14 (20.0) 627 (24.7) 602 (24.9) 4 (17.4) 5697 (33.4)
Graduate school 14 (1.8) 10 (2.6) 1 (1.4) 29 (1.1) 26 (1.1) 0 (0.0) 321 (1.9)
Missing 58 (7.3) 21 (5.4) 3 (4.3) 79 (3.1) 74 (3.1) 2 (8.7) 505 (3.0)
Mother’s occupation
Public servant hired by
the government
6 (0.8) 1 (0.3) 0 (0.0) 0 (0.0) 18 (0.7) 0 (0.0) 64 (0.4)
Company clerks 213 (26.8) 93 (23.8) 13 (18.6) 13 (18.6) 611 (25.3) 3 (13.0) 5226 (30.7)
Industry workers 45 (5.7) 28 (7.2) 6 (8.6) 6 (8.6) 157 (6.5) 2 (8.7) 1232 (7.2)
Self-employed 191 (24.0) 109 (27.9) 21 (30.0) 21 (30.0) 669 (27.7) 6 (26.1) 4451 (26.1)
Other worker 79 (9.9) 27 (6.9) 3 (4.3) 3 (4.3) 237 (9.8) 3 (13.0) 1224 (7.2)
Student 1 (0.1) 1 (0.3) 0 (0.0) 0 (0.0) 3 (0.1) 0 (0.0) 27 (0.2)
Farmer 49 (6.2) 28 (7.2) 11 (15.7) 11 (15.7) 158 (6.5) 2 (8.7) 684 (4.0)
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Table 7 Characteristics of Shenzhen sample within age range during clinical assessments (Continued)
Variables n (%) Group 1: CAST ≥ 15 Group 2: 12–14 Group 3: ≤ 11
Completed Not
completed
Invited and
completed
Invited but not
participated
Not
invited
Invited Not
invited
Unemployed 206 (25.9) 103 (26.3) 16 (22.9) 16 (22.9) 558 (23.1) 7 (30.4) 4102 (24.1)
Missing 6 (0.8) 1 (0.3) 0 (0.0) 0 (0.0) 8 (0.3) 0 (0.0) 40 (0.2)
Father’s occupation
Public servant hired by
the government
8 (1.0) 5 (1.3) 0 (0.0) 0 (0.0) 35 (1.5) 1 (4.4) 244 (1.4)
Company clerks 236 (29.7) 108 (27.6) 23 (32.9) 14 (26.4) 741 (30.6) 11 (47.8) 6385 (37.5)
Industry workers 66 (8.3) 49 (12.5) 8 (11.4) 4 (7.6) 219 (9.1) 1 (4.4) 1489 (8.7)
Self-employed 272 (34.2) 148 (37.9) 25 (35.7) 24 (45.3) 900 (37.2) 6 (26.1) 6242 (36.6)
Other worker 95 (11.9) 34 (8.7) 3 (4.3) 6 (11.3) 262 (10.8) 3 (13.0) 1287 (7.6)
Student 2 (0.3) 0 (0.0) 0 (0.0) 8 (0.1)
Farmer 36 (4.5) 16 (4.1) 6 (8.6) 1 (1.9) 111 (4.6) 0 (0.0) 418 (2.5)
Unemployed 75 (9.4) 31 (7.9) 5 (7.1) 4 (7.6) 148 (6.1) 1 (4.4) 935 (5.5)
Missing 6 (0.8) 0 (0.0) 0 (0.0) 0 (0.0) 3 (0.1) 0 (0.0) 42 (0.3)
Income
≤ 1999 46 (5.8) 31 (7.9) 4 (5.7) 4 (7.6) 135 (5.6) 0 (0.0) 609 (3.6)
2000–3999 181 (22.7) 89 (22.8) 17 (24.3) 14 (26.4) 480 (19.8) 5 (21.7) 2569 (15.1)
4000–5999 156 (19.6) 81 (20.7) 16 (22.9) 12 (22.6) 515 (21.3) 9 (39.1) 3047 (17.9)
6000–7999 104 (13.1) 38 (9.7) 10 (14.3) 7 (13.2) 336 (13.9) 3 (13.0) 2552 (15.0)
8000–9999 68 (8.5) 36 (9.2) 4 (5.7) 4 (7.6) 227 (9.4) 1 (4.4) 2049 (12.0)
≥ 10,000 112 (14.1) 69 (17.7) 10 (14.3) 6 (11.3) 500 (20.7) 3 (13.0) 4699 (27.6)
Missing 129 (16.2) 47 (12.0) 9 (12.9) 6 (11.3) 226 (9.3) 2 (8.7) 1525 (8.9)
Table 8 Age and sex distribution of Jiamusi City sample
Age Sex Missing Total (%)
Boys Girls
6 1918 1916 10 3844 (23.5)
7 1930 1730 11 3671 (22.4)
8 1952 1810 10 3772 (23.1)
9 1875 1908 6 3789 (23.2)
10 230 161 1 392(2.4)
Others 421 328 141 890 (5.4)
Total 8326 7853 179 16,358 (100)
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Table 9 Characteristics of Jiamusi sample within age range during clinical assessments
Variables n (%) Group 1: CAST ≥ 15 Group 2: 12–14 Group 3: ≤ 11
Completed Not
completed
Invited and
completed
Invited but not
participated
Not
invited
Invited Not
invited
Number 414 (46) 487 (54) 144 (8) 124 (7) 1554 (85) 750 (6) 12,190 (94)
CAST score Median (IQR) 16 (15,17) 16 (15.17) 12 (12, 13) 13 (12, 14) 13 (12, 13) 7 (5,9) 7 (5, 9)
Mean (SD) 16 (2.6) 16 (3.9) 12 (1.8) 12 (2.1) 12 (1.8) 7 (2.4) 6 (2.5)
Age Mean (SD) 8.2 (1.3) 7.8 (1.7) 7.9 (1.5) 7.8 (1.3) 8.0 (1.3) 7.9 (1.1) 8.2 (1.1)
Sex
Boys 260 (63) 337 (69) 80 (56) 63 (51) 921 (59) 376 (50) 5979 (49)
Girls 151 (36) 148 (30) 64 (44) 59 (48) 625 (40) 373 (48) 6189 (46)
Missing 3 (0.7) 2 (0.4) 0 (0) 2 (1.6) 8 (0.5) 1 (0.3) 22 (0.2)
Mother’s age
≤ 24 3 (0.7) 2 (0.4) 0 (0) 0 (0) 4 (0.3) 2 (0.3) 27 (0.2)
25–30 64 (15.5) 84 (17.3) 28 (19.4) 16 (12.9) 237 (15.3) 149 (19.9) 1462 (12.0)
31–34 215 (51.9) 230 (47.2) 87 (60.4) 61 (49.2) 831 (53.5) 444 (59.2) 6811 (55.9)
35–40 37 (8.9) 31 (6.4) 10 (6.9) 7 (5.7) 112 (7.2) 50 (6.7) 713 (5.9)
≥ 41 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0.0) 2 (0.0)
Missing 95 (23.0) 140 (28.8) 19 (13.2) 40 (32.3) 370 (23.8) 105 (14.0) 3175 (26.1)
Father’s age
≤ 24 2 (0.5) 3 (0.6) 0 (0.0) 0 (0.0) 6 (0.4) 1 (0.1) 14 (0.1)
25–30 32 (7.7) 37 (7.6) 12 (8.3) 12 (9.7) 108 (7.0) 70 (9.3) 532 (4.4)
31–34 262 (63.3) 280 (57.5) 105 (72.9) 75 (60.5) 937 (60.3) 534 (71.2) 8128 (66.7)
35–40 50 (12.1) 52 (10.7) 16 (11.1) 12 (9.7) 188 (12.1) 68 (9.1) 1223 (10.0)
≥ 41 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.2)
Missing 68 (16.4) 115 (23.6) 11 (7.6) 25 (20.2) 315 (20.3) 77 (10.3) 2291 (18.8)
Mother’s education
Junior high or lower 223 (53.9) 225 (46.2) 97 (67.4) 56 (45.2) 804 (51.7) 496 (66.1) 4583 (37.6)
High school 133 (32.1) 160 (32.9) 36 (25.0) 44 (35.5) 455 (29.3) 194 (25.9) 4258 (34.9)
College or university 37 (32.1) 79 (16.2) 4 (2.8) 20 (16.1) 231 (14.9) 48 (6.4) 2997 (24.6)
Graduate school 6 (1.5) 7 (1.4) 2 (1.4) 1 (0.8) 18 (1.2) 6 (0.8) 217 (1.8)
Missing 15 (3.6) 16 (3.3) 5 (3.5) 3 (2.4) 46 (3.0) 6 (0.8) 135 (1.1)
Father’s education
Junior high or lower 220 (53.1) 209 (42.9) 99 (68.8) 51 (41.1) 743 (47.8) 492 (65.6) 4349 (35.7)
High school 124 (30.0) 152 (31.2) 36 (25.0) 52 (41.9) 506 (32.6) 197 (26.3) 4335 (35.6)
College or university 47 (11.4) 96 (19.7) 5 (3.5) 17 (13.7) 241 (15.5) 44 (5.9) 3047 (25.0)
Graduate school 6 (1.5) 10 (2.1) 2 (1.4) 2 (1.6) 20 (1.3) 8 (1.1) 264 (2.2)
Missing 17 (4.1) 20 (4.1) 2 (1.4) 2 (1.6) 44 (2.8) 9 (1.2) 195 (1.6)
Mother’s occupation
Public servant hired by
the government
15 (3.6) 18 (3.7) 0 (0.0) 4 (3.2) 34 (2.2) 10 (1.3) 363 (3.0)
Company clerks 19 (4.6) 40 (8.2) 8 (5.6) 10 (8.1) 144 (9.3) 66 (8.8) 1586 (13.0)
Industry workers 26 (6.3) 44 (9.0) 5 (3.5) 8 (6.5) 134 (8.6) 31 (4.1) 1578 (13.0)
Self-employed 103 (24.9) 141 (29.0) 32 (22.2) 48 (38.7) 460 (29.6) 188 (25.1) 3735 (30.6)
Other worker 53 (12.8) 44 (9.0) 26 (18.1) 8 (6.5) 156 (10.0) 82 (10.9) 996 (8.2)
Student 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 7 (0.1)
Farmer 99 (23.9) 80 (16.4) 27 (18.8) 24 (19.4) 270 (17.4) 156 (20.8) 1415 (11.6)
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Table 9 Characteristics of Jiamusi sample within age range during clinical assessments (Continued)
Variables n (%) Group 1: CAST ≥ 15 Group 2: 12–14 Group 3: ≤ 11
Completed Not
completed
Invited and
completed
Invited but not
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Not
invited
Invited Not
invited
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Missing 17 (4.1) 21 (4.3) 1 (0.7) 3 (2.4) 49 (3.2) 7 (0.9) 261 (2.1)
Income
≤ 1999 128 (30.9) 141 (29.0) 40 (27.8) 34 (27.4) 346 (22.3) 191 (25.5) 1869 (15.3)
2000–3999 150 (36.2) 161 (33.1) 49 (34.0) 45 (36.3) 550 (35.4) 311 (41.5) 4035 (33.1)
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Missing 35 (8.5) 42 (8.6) 15 (10.4) 5 (4.0) 124 (8.0) 34 (4.5) 560 (4.6)
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